|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
7K01CA184388-03
|
$108,808
|
$108,808
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Genetic and Biochemical Studies of KSHV LANA
|
5R01CA082036-17
|
$421,563
|
$421,563
|
KAYE, KENNETH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect
|
1UH2CA202723-01
|
$500,000
|
$500,000
|
ERICKSON, DAVID
|
CORNELL UNIVERSITY
|
|
Viral Oncology Training Grant
|
5T32CA009111-38
|
$378,220
|
$37,822
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda
|
5U54CA190146-03
|
$693,281
|
$339,708
|
CASPER, COREY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Regional Oncology Research Center
|
3P30CA006973-53S1
|
$60,000
|
$600
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-53S2
|
$114,211
|
$1,142
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-53S3
|
$125,000
|
$1,250
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
4P30CA006973-53
|
$6,995,267
|
$69,953
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Studies of HHV-8 vIL-6 Function
|
2R01CA076445-15
|
$384,750
|
$192,375
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
HHV-8 vIRF interactions in the context of infection
|
5R21CA196348-02
|
$211,410
|
$211,410
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
SEVERABLE FUNDING FOR NCI-FREDERICK
|
261200800001E
|
$248,730,791
|
$17,349
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Research Management and Support
|
RMS ES 2016
|
$320,501,735
|
$20,000
|
N/A
|
National Institutes of Health
|
|
CD206 Targeted Therapy for Kaposi Sarcoma and Tumor Associated Macrophages
|
1R44CA206788-01
|
$232,464
|
$232,464
|
COPE, FREDERICK
|
NAVIDEA BIOPHARMACEUTICALS, INC.
|
|
Receptor Mediated SPECT Imaging Of Kaposi Sarcoma With 99mTc-Tilmanocept
|
4R44CA192859-02
|
$633,492
|
$633,492
|
COPE, FREDERICK
|
NAVIDEA BIOPHARMACEUTICALS, INC.
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,014,935
|
$20,299
|
Barr, Frederic
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,305,516
|
$215,276
|
Bilusic, Marijo
|
CCR (NCI)
|
|
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs
|
ZIA BC 007363
|
$287,033
|
$143,516
|
Burke, Terrence
|
CCR (NCI)
|
|
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
|
ZIA BC 010791
|
$1,047,897
|
$209,579
|
Carrington, Mary
|
CCR (NCI)
|
|
HIV AIDS cancer match, U.S.
|
ZIA CP010150-10071
|
$196,073
|
$58,822
|
Engels, Eric
|
DCEG (NCI)
|
|
Cancer risk in solid organ transplant recipients and endstage renal disease
|
ZIA CP010150-10362
|
$240,777
|
$24,078
|
Engels, Eric
|
DCEG (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$373,564
|
$37,356
|
Gottesman, Michael
|
CCR (NCI)
|
|
Studies on drug resistance in HIV-related Kaposi's sarcoma
|
ZIA BC 011730
|
$149,425
|
$37,356
|
Gottesman, Michael
|
CCR (NCI)
|
|
Medical Oncology HIV-AIDS Clinical Research
|
ZID BC 011683
|
$173,361
|
$52,008
|
Gulley, James
|
CCR (NCI)
|
|
KSHV/HHV8 in sickle cell and other Ugandan populations
|
ZIA CP010176-10076
|
$8,347
|
$6,678
|
Mbulaiteye, Sam
|
DCEG (NCI)
|
|
KS gene expression & clonality
|
ZIA CP010176-10082
|
$4,899
|
$4,899
|
Mbulaiteye, Sam
|
DCEG (NCI)
|
|
CCR VB FACS CORE
|
ZIC BC 010936
|
$311,605
|
$62,321
|
McKinnon, Katherine
|
CCR (NCI)
|
|
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors
|
ZIA BC 011109
|
$174,730
|
$8,737
|
Mitsuya, Hiroaki
|
CCR (NCI)
|
|
HIV Integrase Modeling and Computer-Aided Inhibitor and Microbicide Development
|
ZIA BC 010524
|
$248,338
|
$124,169
|
Nicklaus, Marc
|
CCR (NCI)
|
|
DNA Vaccines
|
ZIA BC 010749
|
$1,069,955
|
$534,978
|
Pavlakis, George
|
CCR (NCI)
|
|
Molecular Diagnostics Core Laboratory
|
ZIC BC 011079
|
$1,229,493
|
$61,475
|
Raffeld, Mark
|
CCR (NCI)
|
|
Development of a Vaccine for HIV-AIDS: Humoral Immunity
|
ZIA BC 011058
|
$2,157,963
|
$647,389
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Development of a Vaccine for HIV-AIDS: Cellular Immunity
|
ZIA BC 011062
|
$269,745
|
$89,016
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Development of a Vaccine for HIV-AIDS: Translation to the Clinic
|
ZIA BC 011063
|
$269,745
|
$89,016
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Biostatistics and Data Management Section
|
ZID SC 007202
|
$560,999
|
$28,050
|
Steinberg, Seth
|
CCR (NCI)
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$268,745
|
$107,498
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Patient Oriented Research in Viral Malignancies and HIV-associated Cancers
|
ZIA BC 011700
|
$764,229
|
$458,537
|
Uldrick, Thomas
|
CCR (NCI)
|
|
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
|
ZIA BC 010885
|
$438,983
|
$131,695
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Clinical Trials of Patients with AIDS-Related Malignancies
|
ZIA BC 010888
|
$457,274
|
$137,182
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Development of Novel Therapies for HIV Infection
|
ZIA SC 006737
|
$18,291
|
$5,487
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses
|
ZIA SC 010357
|
$869,541
|
$173,908
|
Zheng, Zhi-Ming
|
CCR (NCI)
|
|
Functions of KSHV microRNAs
|
ZIA BC 011176
|
$452,468
|
$226,234
|
Ziegelbauer, Joseph
|
CCR (NCI)
|
|
Kaposi's Sarcoma-associated Herpesvirus Mimics of Cellular microRNAs
|
5R01CA180813-03
|
$320,588
|
$320,588
|
GOTTWEIN, EVA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-22S1
|
$79,482
|
$795
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-22S2
|
$202,481
|
$2,025
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
4P30CA060553-22
|
$4,865,180
|
$48,652
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-18S3
|
$1,479,340
|
$118,347
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-18S4
|
$124,995
|
$10,000
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-18S5
|
$749,999
|
$60,000
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-18S6
|
$60,000
|
$4,800
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
Total relevant funding to Kaposi Sarcoma for this search: $28,270,267
|